Autoantibody in schizophrenia? Elementary, my dear Lennox

3550755709_d8be7ba08b_z (1)

Carmine Pariante considers the implications of a recent case-control study, which looks at the prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis.

[read the full story...]

Nicotine reverses hypofrontality in animal models of addiction and schizophrenia

Screen Shot 2017-03-06 at 17.02.56

Marcus Munafo looks at a complex and sophisticated series of experiments that provide further insight into the relationships between genetic risk, cigarette smoking and schizophrenia.

[read the full story...]

A crisis map: charting the topography of home treatment

rgyglpwwjb0-richard-tilney-bassett

Derek Tracy and Lisa Lloyd look back over the last 17 years of mental health crisis care and consider the findings of a new survey of Crisis Resolution Teams in England.

[read the full story...]

Omega-3 fatty acids to prevent psychosis: the importance of replication (NEURAPRO trial)

22421169767_03c5cce9cf_z

Raphael Underwood summarises the NEURAPRO trial, which concludes that Omega-3 fatty acids are no better than placebo at preventing transition to psychosis in young people at ultrahigh risk for psychotic disorders.

[read the full story...]

The role of pets in supporting people living with mental distress

Cat for Alison Faulkner blog

Alison Faulkner (and her cats) delight in a recent qualitative study looking at the impact pets can have on the everyday lives of people diagnosed with a long-term mental health condition.

[read the full story...]

#MQScienceMeeting: transforming lives with better mental health research

MQ MHSM

André Tomlin looks back at the #MQScienceMeeting Mental Health Science Meeting that took place in London on 2-3 Feb 2017.

[read the full story...]

In search of the sweet spot: the links between dysglycaemia and first episode psychosis

lump-sugar-549096_1280

Ben Perry publishes his debut blog on a recent systematic review of impaired glucose homeostasis in first-episode schizophrenia.

[read the full story...]

Risperidone versus placebo for people with schizophrenia

14397363653_f60cbb91b2_k

Joanne Wallace summarises the recent Cochrane systematic review on risperidone versus placebo for schizophrenia, which concludes that the best available evidence does not show that the benefits of risperidone outweigh the harms.

[read the full story...]

Shared treatment decision-making: does it help people with psychosis?

4253324789_4e29308f29_o

Matthew Broome on a systematic review and meta-analysis of shared treatment decision-making and empowerment-related outcomes in psychosis.

[read the full story...]

Substance misuse and addiction in people with intellectual and developmental disabilities

drinking-997189_640

Andrew Jones summarises a recent Canadian cohort study, which explores the extent of substance misuse and addictive disorders among adults with intellectual and developmental disabilities.

[read the full story...]